Desglucocheirotoxin



Compound IDCDAMM00786
Common nameDesglucocheirotoxin
IUPAC name5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde
Molecular formulaC29H42O10

Experimental data

Retention time0.39
Adduct[M+K]+
Actual mz589.244
Theoretical mz589.241
Error5.33
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.4643

Identifiers and class information

Inchi keyHULMNSIAKWANQO-UHFFFAOYNA-N
SmilesO=CC12CCC(OC3OC(C)C(O)C(O)C3O)CC2(O)CCC4C1CCC5(C)C(C6=CC(=O)OC6)CCC45O
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)8
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)550.645
Computed dipole moment(dipole)14.198
Total solvent accessible surface area (SASA)775.874
Hydrophobic component of SASA (FOSA)485.399
Hydrophilic component of SASA (FISA)260.847
Pie component of the SASA (PISA)29.628
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1542.41
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)14
Free energy of solvation of dipole (dip^2/V)0.130691
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0360883
Globularity descriptor (glob)0.832095
Predicted polarizability in cubic angstroms (QPpolrz)50.719
Predicted hexadecane/gas partition coefficient (QPlogPC16)15.358
Predicted octanol/gas partition coefficient (QPlogPoct)32.462
Predicted water/gas partition coefficient (QPlogPw)21.446
Predicted octanol/water partition coefficient (QPlogPo/w)1.17
Predicted aqueous solubility (QPlogS)-4.288
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.885
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.39
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)33.288
Predicted brain/blood partition coefficient (QPlogBB)-2.43
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)12.506
Predicted skin permeability, log Kp (QPlogKp)-5.454
PM3 calculated ionization potential (IP(ev))10.009
PM3 calculated electron affinity (EA(eV))0.685
Number of likely metabolic reactions (#metab)7
Prediction of binding to human serum albumin (QPlogKhsa)-0.163
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)48.086
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)174.531
Number of nitrogen and oxygen atoms (#NandO)10
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P56817BACE1Beta-secretase 1T79031SwissTargetPrediction
P28482MAPK1MAP kinase ERK2T58970SwissTargetPrediction
P09619PDGFRBPlatelet-derived growth factor receptor betaT59102SwissTargetPrediction
P05023ATP1A1Sodium/potassium-transporting ATPase alpha-1 chainT40800SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SwissTargetPrediction

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T79031DI0025Alzheimer disease[ICD-11: 8A20]P56817BACE1
T58970DI0036Arteries/arterioles disorder[ICD-11: BD52]P28482MAPK1
T58970DI0252Melanoma[ICD-11: 2C30]P28482MAPK1
T58970DI0326Pancreatic cancer[ICD-11: 2C10]P28482MAPK1
T58970DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P28482MAPK1
T59102DI0009Acute diabete complication[ICD-11: 5A2Y]P09619PDGFRB
T59102DI0361Renal cell carcinoma[ICD-11: 2C90]P09619PDGFRB
T59102DI0403Thrombocytopenia[ICD-11: 3B64]P09619PDGFRB
T40800DI0068Cardiac arrhythmia[ICD-11: BC9Z]P05023ATP1A1
T40800DI0086Chronic obstructive pulmonary disease[ICD-11: CA22]P05023ATP1A1
T40800DI0101Corneal disease[ICD-11: 9A76-9A78]P05023ATP1A1
T40800DI0175Heart failure[ICD-11: BD10-BD1Z]P05023ATP1A1
T40800DI0186Hyperhidrosis[ICD-11: EE00]P05023ATP1A1
T40800DI0243Malaria[ICD-11: 1F40-1F45]P05023ATP1A1
T40800DI0397Supraventricular tachyarrhythmia[ICD-11: BC81]P05023ATP1A1
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2

Copyright © 2025